Abstract
The purpose of immunogenetic testing in kidney transplantation is to minimize post-transplant acute rejection episodes and to decrease the intensity of chronic rejection. To the degree that the kidney donor is mismatched with the recipient there will be an increased number of targets for both the cellular and humoral immune responses. To the degree that the recipient has been sensitized against donor antigens, there will be greater risk for rejection episodes. This chapter is an exposition of what histocompatibility testing is and how it is done.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J. Nomenclature for factors of the HLA system, 2004. Int J Immunogenet 2005; 32:107–159.
Auchincloss H Jr, Sultan H. Antigen processing and presentation in transplantation. Curr Opin Immunol 1996; 8:681–687.
Morin-Papunen L, Tiilikainen A, Hartikainen-Sorri AL. Maternal HLA immunization during pregnancy: presence of anti HLA antibodies in half of multigravidous women. Med Biol 1984; 62:323–325.
Macleod AM, Hillis AN, Mather A, Bone JM, Catto GR. Effect of cyclosporin, previous third-party transfusion, and pregnancy on antibody development after donor-specific transfusion before renal transplantation. Lancet 1987; 1:416–418.
Doxiadis II, Claas FH. The short story of HLA and its methods. Dev Ophthalmol 2003; 36:5–11.
Fussell H, Thomas M, Street J, Darke C. HLA-A9 antibodies and epitopes. Tissue Antigens 1996; 47:307–312.
Patel R, Mickey MR, Terasaki PI. Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. N Engl J Med 1968; 279:501–506.
Marrari M, Duquesnoy RJ. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A,B,C typing, antibody screening, and lymphocytotoxicity crossmatching. American Society for Histocompatibility and Immunogenetics. College of American Pathologists. Hum Immunol 1994; 39:87–95.
Duquesnoy RJ, Marrari M. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. II. HLA-DR, DQ serologic typing, antibody identification, and B-cell crossmatching. American Society for Histocompatibility of Immunogenetics. College of American Pathologists. Hum Immunol 1994; 39:96–105.
Lightbody JJ, Rosenberg JC. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients. J Immunol 1974; 112:890–896.
Gailiunas P Jr., Suthanthiran M, Busch GJ, Carpenter CB, Garovoy MR. Role of humoral presenitization in human renal transplant rejection. Kidney Int 1980; 17:638–646.
Kerman RH, Kimball PM, Van Buren CT, Lewis RM, DeVera V, Baghdahsarian V, Heydari A, Kahan BD. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival. Transplantation 1991; 51:316–320.
Okuno T, Kondelis N. Evaluation of dithiothreitol (DTT) for inactivation of IgM antibodies. J Clin Pathol 1978; 31:1152–1155.
Lavee J, Kormos RL, Duquesnoy RJ, Zerbe TR, Armitage JM, Vanek M, Hardesty RL, Griffith BP. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant 1991; 10:921–929; discussion 929–930.
Loh E, Bergin JD, Couper GS, Mudge GH Jr.. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant 1994; 13:194–201.
Tait BD, Hudson F, Cantwell L, Brewin G, Holdsworth R, Bennett G, Jose M. Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology (Carlton) 2009; 14:247–254.
Pei R, Lee J, Chen T, Rojo S, Terasaki PI. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 1999; 60:1293–1302.
Dragun D. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation. Transplantation 2008; 86(8):1019–1025.
Stastny P, Zou Y, Fan Y, Qin Z, Lavingia B. The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells. Contrib Nephrol 2009; 162:99–106.
Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007; 7:408–415.
Zou Y, Stastny P, Süsal C, Döhler B, Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007; 357:1293–1300.
Breimer ME, Rydberg L, Jackson AM, Lucas DP, Zachary AA, Melancon JK, Von Visger J, Pelletier R, Saidman SL, Williams WW Jr, Holgersson J, Tyden G, Klintmalm GK, Coultrup S, Sumitran-Holgersson S, Grufman P. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 2009; 87(4):549–556.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag US
About this chapter
Cite this chapter
Milford, E.L., Guleria, I. (2010). What Is Histocompatibility Testing and How Is It Done?. In: McKay, D., Steinberg, S. (eds) Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1690-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1690-7_4
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1689-1
Online ISBN: 978-1-4419-1690-7
eBook Packages: MedicineMedicine (R0)